Introduction
Arthrosamid is an innovative treatment for knee osteoarthritis , involving the injection of a polyacrylamide hydrogel into the joint. This gel helps cushion and support the joint lining, reducing pain and improving movement for people with osteoarthritis . As more people hear about Arthrosamid , many UK patients and their families want to know how they can access this option. Navigating the system can be confusing—especially when considering the NHS, private health insurance, or self-funding.
In this article, we’ll break down the current routes to Arthrosamid treatment in the UK, including availability in the NHS, how private health insurance handles it, and what to consider if you’re thinking of paying for it yourself.
Arthrosamid and the NHS: What’s the Current Situation?
The NHS has a thorough process for assessing new treatments like Arthrosamid . Before something is offered routinely, NHS authorities—guided by the National Institute for Health and Care Excellence (NICE)—evaluate its safety, effectiveness, and value for money.
Right now, Arthrosamid is licensed for use in the UK and holds a CE mark, but it’s not yet widely available through the NHS for knee osteoarthritis . Because the treatment is still quite new and long-term studies are ongoing, NHS funding isn’t widespread. While some local NHS areas may be considering it, most patients will find that Arthrosamid isn’t offered as a standard treatment just yet. This means those interested in getting it through the NHS may have to wait until more evidence becomes available.
Private Health Insurance: How Does It Cover Arthrosamid?
Private health insurance opens up more options, but there are still a few hoops to jump through. Major UK insurers like Bupa, Aviva, and AXA Health assess new treatments on a case-by-case basis. Whether they cover Arthrosamid largely depends on clinical evidence and what’s included in your policy.
In most cases, you’ll need a referral from a specialist—such as an orthopaedic surgeon or rheumatologist—who can show that Arthrosamid is the most suitable treatment for you. Insurers usually require pre-approval (prior authorisation) before you proceed with treatment. Since Arthrosamid is still relatively new, some insurers may view it as experimental and could ask for extra paperwork or justification before agreeing to cover the cost.
Insurance coverage details can vary, so it’s essential to speak directly with your insurer to understand their specific position and what documents are needed. Interestingly, research has found that many people with private insurance sometimes continue with NHS care, often due to satisfaction with NHS services and short waiting times (Fairbank et al., 1990). Additionally, shifts in the insurance market—and factors like changing demographics—can influence insurance availability and premiums over time (Brown & Connelly, 2005).
It’s also worth noting that people’s choice to use private insurance often depends on personal factors like service quality and affordability, not just the treatment itself (Karimi, 2012). So when weighing your options, consider both your insurance terms and your own priorities around comfort, cost, and speed of access.
Self-Funding, Payment Plans, and Other Access Routes
If you don’t have insurance cover for Arthrosamid or it isn’t available on the NHS, you can choose to pay privately. Several specialist clinics throughout the UK now offer Arthrosamid injections . The cost will vary depending on the clinic and location.
Many clinics offer payment plans or financing options to help make treatment more affordable. There may also be patient access programs, clinical trials, or compassionate use schemes where eligible patients can receive the treatment at a reduced cost or even for free. If you’re interested in these options, talk to your healthcare provider or contact clinics directly to see what might be available.
Common Questions About Arthrosamid Access
Do I need a referral to get Arthrosamid privately or through insurance?
Yes, nearly all providers and insurers require a referral from a relevant specialist to confirm that Arthrosamid is an appropriate option for your condition.
Is pre-approval from my insurer necessary before starting treatment?
Usually, yes. Pre-approval gives you confirmation that your insurer will cover the costs. Without this, you might have to pay for the treatment yourself.
Will Arthrosamid be available on the NHS in the near future?
While it’s difficult to predict exact timelines, as more research emerges supporting Arthrosamid ’s safety and effectiveness, NHS funding decisions will likely be re-evaluated. Keeping in regular contact with your specialist and staying up to date with NHS announcements is the best way to track progress.
Conclusion: Taking Control of Your Treatment Choices
Arthrosamid offers hope for people living with knee osteoarthritis , providing a new way to manage pain and improve mobility. Though not yet widely accessible on the NHS, private insurance and self-funding routes are available—each with their own requirements and steps.
The most important part of this process is open communication: keep talking with your healthcare team and your insurer, ask questions, and weigh all your options. Being informed and proactive puts you in the best position to make decisions that suit your needs. Whether the path is through the NHS in the future or through private care today, Arthrosamid could be a valuable step in managing your knee osteoarthritis .
References
Fairbank, A. C., Stapleton, S. R., & Jarrett, P. E. (1990). Patients with private health insurance using NHS facilities in preference to private care. BMJ, 300(6726), 719. https://doi.org/10.1136/bmj.300.6726.719
Brown, H. S., & Connelly, L. B. (2005). Lifetime cover in private insurance markets. International Journal of Health Care Finance and Economics, 5(1), 75-88. https://doi.org/10.1007/s10754-005-6602-6
Karimi, M. (2012). Customer preference of private insurance covers in Iran. African Journal of Business Management, 6(11).
Frequently Asked Questions
Arthrosamid® is an innovative polyacrylamide hydrogel injection that cushions the knee joint. At AMSK Clinic, we offer this new approach, supporting patients who seek alternatives to medications or surgery to help reduce pain and improve movement for knee osteoarthritis.
Currently, Arthrosamid® is not widely available on the NHS due to ongoing long-term evaluations. However, AMSK Clinic provides private access for eligible patients, giving more immediate options for those who wish to consider this promising treatment.
Most health insurers assess Arthrosamid® on a case-by-case basis and usually require a specialist referral. AMSK Clinic’s experienced team assists patients with obtaining necessary documentation and liaising with insurers to support potential coverage for this advanced treatment.
At AMSK Clinic, we offer self-funding pathways, payment plans, and information about potential patient access programmes. Our knowledgeable staff guide patients regarding all available finance options, ensuring affordability is addressed while delivering high-quality, specialist care.
AMSK Clinic is a dedicated specialist centre with extensive experience in Arthrosamid® treatment. We provide individualised care, expert guidance through every step, and convenient private options—helping patients confidently explore advanced therapies for knee osteoarthritis without unnecessary delays.
